Metabolic‐associated fatty liver disease is associated with severity of COVID‐19

The Corona Virus Disease 2019 (COVID‐19) pandemic has attracted increasing worldwide attention. While metabolic‐associated fatty liver disease (MAFLD) affects a quarter of world population, its impact on COVID‐19 severity has not been characterized. We identified 55 MAFLD patients with COVID‐19, who...

Full beskrivning

Sparad:
Bibliografiska uppgifter
I publikationen:Liver Int
Huvudupphovsmän: Zhou, Yu‐Jie, Zheng, Kenneth I., Wang, Xiao‐Bo, Sun, Qing‐Feng, Pan, Ke‐Hua, Wang, Ting‐Yao, Ma, Hong‐Lei, Chen, Yong‐Ping, George, Jacob, Zheng, Ming‐Hua
Materialtyp: Artigo
Språk:Inglês
Publicerad: John Wiley and Sons Inc. 2020
Ämnen:
Metabolic & Toxic Liver Diseases
Länkar:https://ncbi.nlm.nih.gov/pmc/articles/PMC7361853/
https://ncbi.nlm.nih.gov/pubmed/32573883
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/liv.14575
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!

Liknande verk